Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$72.25 - $168.95 $112,204 - $262,379
-1,553 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $878 - $1,251
-7 Reduced 0.45%
1,553 $265,000
Q3 2020

Nov 12, 2020

BUY
$127.12 - $172.34 $12,712 - $17,234
100 Added 6.85%
1,560 $219,000
Q2 2020

Aug 13, 2020

BUY
$93.0 - $171.7 $135,780 - $250,681
1,460 New
1,460 $234,000
Q3 2019

Nov 08, 2019

SELL
$72.81 - $156.91 $128,364 - $276,632
-1,763 Closed
0 $0
Q2 2019

Aug 07, 2019

BUY
$112.21 - $151.95 $197,826 - $267,887
1,763 New
1,763 $268,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.